scholarly journals Side Effect Similarity of A0A022RDQ0 Protein and Cyclooxygenases during Drug Targeting in Cancer Treatment

2020 ◽  
Vol 10 (2) ◽  
pp. 17-24
Author(s):  
Anakaa, T.M, et al., Anakaa, T.M, et al., ◽  
Keyword(s):  
Cancer Treatment ◽  
Side Effect ◽  
Drug Targeting

Design of Novel Photosensitizers and Controlled Singlet Oxygen Generation for Photodynamic Therapy

2021 ◽  
Author(s):  
Esra Tanrıverdi Eçik ◽  
Onur BULUT ◽  
Hasan Hüseyin Kazan ◽  
Elif Şenkuytu ◽  
Bunyemin Cosut
Keyword(s):  
Photodynamic Therapy ◽  
Cancer Treatment ◽  
Singlet Oxygen ◽  
Side Effect ◽  
Side Effect Profile ◽  
High Ability ◽  
Lower Side ◽  
Oxygen Generation ◽  
Singlet Oxygen Generation ◽  
Promising Strategy

Photodynamic therapy (PDT) is a promising strategy in cancer treatment with its relatively lower side effect profile. Undoubtedly, the key component of PDT is the photosensitizers with a high ability...

Is Fatigue a Long-term Side Effect of Breast Cancer Treatment?

1999 ◽  
Vol 6 (3) ◽  
pp. 256-263 ◽  
Author(s):  
Paul B. Jacobsen ◽  
Kevin Stein
Keyword(s):  
Breast Cancer ◽  
Cancer Treatment ◽  
Side Effect ◽  
Breast Cancer Treatment

Bacterial cellulose based composites enhanced transdermal drug targeting for breast cancer treatment

2019 ◽  
Vol 370 ◽  
pp. 749-759 ◽  
Author(s):  
Ling-Kun Zhang ◽  
Shiwei Du ◽  
Xiaozhen Wang ◽  
Yuxuan Jiao ◽  
Liang Yin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Treatment ◽  
Bacterial Cellulose ◽  
Drug Targeting ◽  
Breast Cancer Treatment

scholarly journals Paraneoplastic glomerular disease: The struggle is real

2019 ◽  
Vol 3 (1) ◽  
pp. 31-38 ◽  
Author(s):  
Pooja Amarapurkar ◽  
Salim Bou-Slaiman ◽  
Bianca Madrid ◽  
Marco Ladino
Keyword(s):  
Chronic Kidney Disease ◽  
Acute Kidney Injury ◽  
Kidney Disease ◽  
Cancer Treatment ◽  
Side Effect ◽  
Kidney Injury ◽  
Glomerular Diseases ◽  
The Past ◽  
Underlying Malignancy ◽  
Paraneoplastic Diseases

Over the past decade, the relationships between various kidney disease and cancer have been established, but not fully elucidated. Development of acute kidney injury or chronic kidney disease as a side effect of cancer treatment is not uncommon. However, renal paraneoplastic diseases are rather unique and less known examples of the association between kidney disease and cancer. These conditions are of importance to the nephrologist as they may be the initial presentation of an underlying malignancy and may not respond to the usual therapies used for their non-paraneoplastic variants. This article will discuss the pathogenesis and challenges in management of paraneoplastic glomerular diseases.

Skin and mucosal alterations

2007 ◽  
pp. 635-652
Keyword(s):  
Body Image ◽  
Cancer Treatment ◽  
Advanced Cancer ◽  
Oral Mucositis ◽  
Hair Loss ◽  
Side Effect ◽  
Oral Care ◽  
Scalp Cooling ◽  
It Impacts ◽  
Scalp Hypothermia

Hair loss (alopecia) 636 Scalp cooling (scalp hypothermia) 638 Oral mucositis and related problems 640 Oral mucositis: managing the process and symptoms 644 Oesophagitis 646 Oral care in advanced cancer 647 Malignant wounds 648 Lymphoedema 650 Hair loss can be a distressing side effect of cancer treatment; it impacts on body image and feelings of attractiveness, creates anxiety and causes a visual reminder of the disease and treatment. Alopecia is not a major side effect for most people, but a small group of patients will become extremely distressed by it....

Nasal vestibulitis as an under-recognized and undertreated side effect of cancer treatment.

2017 ◽  
Vol 35 (31_suppl) ◽  
pp. 219-219
Author(s):  
Elizabeth Jane Cathcart-Rake ◽  
DeAnne R. Smith ◽  
Charles L. Loprinzi
Keyword(s):  
Cancer Treatment ◽  
Targeted Therapies ◽  
Side Effect ◽  
Chart Review ◽  
Respiratory Illness ◽  
Concurrent Infection ◽  
Cancer Treatments ◽  
Treatment Regimens ◽  
Nasal Symptoms ◽  
Nasal Swabs

219 Background: Dryness, crusting, and bleeding of the nares due to inflammation, termed nasal vestibulitis (NV), is infrequently reported as a side effect of cancer treatments. However, one study described 115 patients who developed NV while undergoing targeted therapies; many were treated with bacitracin ointment (Ruiz et al Sup Care Cancer 2015). Methods: This study surveyed 94 patients regarding the presence of nasal symptoms during cancer treatments. Participants were consented for the study if they had undergone at least 6 weeks of cancer-directed therapy in the Mayo Clinic Chemotherapy Unit. They were asked about types of nasal symptoms, severity, and symptom treatments. A chart review was then conducted to determine documentation of symptoms, the presence of concurrent illnesses, and cancer treatment regimens. Results: Ninety-four patients completed questionnaires, with 41% reporting unpleasant nasal symptoms that they attributed to cancer treatments. Of the symptomatic patients, 46% had dryness, 33% had discomfort, 54% had bleeding, and 46% had scabbing. Average severity was 1.9 on a scale from 1 to 3 (1 = mild, 3 = severe). Symptoms were noted in patients undergoing a variety of cancer treatment regimens, with the highest frequency in patients undergoing a taxane-containing regimen (46%). 62% of patients with symptoms said they reported them to their provider, but only 41% of chart notes (for 16 patients) contained documentation of such, most frequently described as “allergies” or “epistaxis.” Only 10% of symptomatic patients had nasal swabs; all of which were obtained during respiratory illness or pre-op. 49% of patients with nasal symptoms reported treating their symptoms. Antihistamines (7 patients), nasal saline (6 patients), or nasal lubricants (i.e. Vaseline; 7 patients) were used; 2 patients applied bacitracin. 18% of symptomatic patients had providers who recommended treatments, including 2 patients who were thought to have concurrent infection and were treated with antibiotics. Conclusions: NV symptoms are prevalent among oncology patients, but infrequently recorded or treated by providers.

Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?

2018 ◽  
Vol 26 (11) ◽  
pp. 3909-3914
Author(s):  
Elizabeth Cathcart-Rake ◽  
Deanne Smith ◽  
David Zahrieh ◽  
Aminah Jatoi ◽  
Ping Yang ◽  
...  
Keyword(s):  
Cancer Treatment ◽  
Side Effect

Magnetic Drug Targeting—Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment

2003 ◽  
Vol 11 (3) ◽  
pp. 139-149 ◽  
Author(s):  
Christoph Alexiou ◽  
Roland Jurgons ◽  
Roswitha J. Schmid ◽  
Christian Bergemann ◽  
Julia Henke ◽  
...  
Keyword(s):  
Cancer Treatment ◽  
Drug Targeting ◽  
Chemotherapeutic Agent ◽  
Magnetic Drug Targeting ◽  
Magnetic Carrier
Sign in / Sign up

Export Citation Format

Share Document